Parkinson’s Disease Statistics in the U.S.

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.

Parkinson’s Disease Statistics in the U.S.

Parkinson’s disease (PD) is a common neurodegenerative disorder in the United States, with increasing prevalence due to an aging population. Below are key statistics related to Parkinson’s disease in the U.S.:

Prevalence

Approximately 1 million people in the U.S. are living with Parkinson’s disease.
Parkinson’s disease affects about 1-2% of people over the age of 65.
The U.S. sees around 60,000 new cases of Parkinson’s disease diagnosed each year.
By 2030, the number of individuals with Parkinson’s disease in the U.S. is projected to increase significantly due to the growing elderly population.

Incidence

The incidence of Parkinson’s disease (the number of new cases diagnosed annually) in the U.S. is estimated to be 13-16 per 100,000 people.
The risk of developing Parkinson’s increases with age, and most cases occur in individuals over 60 years old.

Age and Gender

Age: Parkinson’s disease primarily affects older adults, with the average age of diagnosis being around 60 years.
- It is rare in younger individuals, though early-onset Parkinson’s disease, which is diagnosed before the age of 50, accounts for about 10-20% of cases.
Gender: Men are about 1.5 times more likely to develop Parkinson’s disease than women in the U.S.

Economic Burden

The economic impact of Parkinson’s disease in the U.S. is significant. The annual cost of Parkinson’s disease is estimated to be around $52 billion.
- This includes direct medical costs (hospitalizations, medications, treatment) of approximately $25.4 billion.
- Indirect costs, including loss of income, disability, and caregiving, account for an additional $26.5 billion annually.
Parkinson’s disease patients incur medical costs that are, on average, 1.5 times higher than those without the disease.

Treatment Statistics

The majority of people with Parkinson’s disease are treated with levodopa, the most common and effective medication for managing symptoms.
Deep Brain Stimulation (DBS) surgery is an option for individuals with advanced Parkinson’s or those who do not respond well to medication. Each year, around 4,000-6,000 DBS surgeries are performed in the U.S. for Parkinson’s disease.

Mortality

While Parkinson’s disease itself is not typically the direct cause of death, complications from the disease, such as falls, pneumonia, or swallowing difficulties, can lead to fatal outcomes.
Parkinson’s disease is the 14th leading cause of death in the U.S., with approximately 30,000 deaths annually attributed to the disease or related complications.

Geographic Distribution

The prevalence of Parkinson’s disease varies by region in the U.S., with higher rates observed in the Midwest and Northeast. These areas tend to have older populations, which may explain the higher numbers of cases.
States with larger elderly populations, such as Florida, Pennsylvania, and California, have the highest numbers of individuals with Parkinson’s disease.

Risk Factors

Aging: The risk of Parkinson’s increases with age. Most cases are diagnosed after the age of 60, though it can occur earlier.
Family History: A family history of Parkinson’s increases the risk of developing the disease, especially if specific genetic mutations are present.
Environmental Factors: Exposure to certain pesticides, heavy metals, and industrial chemicals may increase the risk of developing Parkinson’s disease. Farmers and individuals living in rural areas have been found to have higher rates of Parkinson’s in some studies.

Conclusion

Parkinson’s disease affects approximately 1 million people in the U.S., with the majority of cases diagnosed in individuals over 60 years old. As the population ages, the number of people living with Parkinson’s is expected to rise, along with the economic burden of the disease. Men are more likely to develop Parkinson’s than women, and the disease is more common in certain regions of the U.S.